A Study of the Clinical Activity and Safety of JNJ-64041809, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Apalutamide Versus Apalutamide in Subjects With Metastatic Castration-resistant Prostate Cancer

Name: A Study of the Clinical Activity and Safety of JNJ-64041809, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Apalutamide Versus Apalutamide in Subjects With Metastatic Castration-resistant Prostate Cancer
License: Public Domain

Janssen Research & Development, LLC

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

prostatic neoplasms, castration-resistant

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 154693
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.